scispace - formally typeset
Search or ask a question
Institution

Veterans Health Administration

GovernmentWashington D.C., District of Columbia, United States
About: Veterans Health Administration is a government organization based out in Washington D.C., District of Columbia, United States. It is known for research contribution in the topics: Population & Veterans Affairs. The organization has 63820 authors who have published 98417 publications receiving 4835425 citations. The organization is also known as: VHA.


Papers
More filters
Journal ArticleDOI
TL;DR: The goal of this review is to summarize the strengths and weaknesses of existing models of lung injury and help guide investigators in the design and interpretation of animal studies of acute lung injury.
Abstract: Acute lung injury in humans is characterized histopathologically by neutrophilic alveolitis, injury of the alveolar epithelium and endothelium, hyaline membrane formation, and microvascular thrombi. Different animal models of experimental lung injury have been used to investigate mechanisms of lung injury. Most are based on reproducing in animals known risk factors for ARDS, such as sepsis, lipid embolism secondary to bone fracture, acid aspiration, ischemia-reperfusion of pulmonary or distal vascular beds, and other clinical risks. However, none of these models fully reproduces the features of human lung injury. The goal of this review is to summarize the strengths and weaknesses of existing models of lung injury. We review the specific features of human ARDS that should be modeled in experimental lung injury and then discuss specific characteristics of animal species that may affect the pulmonary host response to noxious stimuli. We emphasize those models of lung injury that are based on reproducing risk factors for human ARDS in animals and discuss the advantages and disadvantages of each model and the extent to which each model reproduces human ARDS. The present review will help guide investigators in the design and interpretation of animal studies of acute lung injury.

1,453 citations

Journal ArticleDOI
TL;DR: Neuroimaging and neuropsychological data supply compelling support for the view that a closed-loop circuit represents the major architectural unit of cerebro-cerebellar interactions and provides the cerebellum with the anatomical substrate to influence the control of movement and cognition.
Abstract: Does the cerebellum influence nonmotor behavior? Recent anatomical studies demonstrate that the output of the cerebellum targets multiple nonmotor areas in the prefrontal and posterior parietal cortex, as well as the cortical motor areas. The projections to different cortical areas originate from distinct output channels within the cerebellar nuclei. The cerebral cortical area that is the main target of each output channel is a major source of input to the channel. Thus, a closed-loop circuit represents the major architectural unit of cerebro-cerebellar interactions. The outputs of these loops provide the cerebellum with the anatomical substrate to influence the control of movement and cognition. Neuroimaging and neuropsychological data supply compelling support for this view. The range of tasks associated with cerebellar activation is remarkable and includes tasks designed to assess attention, executive control, language, working memory, learning, pain, emotion, and addiction. These data, along with the revelations about cerebro-cerebellar circuitry, provide a new framework for exploring the contribution of the cerebellum to diverse aspects of behavior.

1,452 citations

Journal ArticleDOI
TL;DR: New persistent opioid use after surgery is common and is not significantly different between minor and major surgical procedures but rather associated with behavioral and pain disorders, which suggests its use is not due to surgical pain but addressable patient-level predictors.
Abstract: Importance Despite increased focus on reducing opioid prescribing for long-term pain, little is known regarding the incidence and risk factors for persistent opioid use after surgery. Objective To determine the incidence of new persistent opioid use after minor and major surgical procedures. Design, Setting, and Participants Using a nationwide insurance claims data set from 2013 to 2014, we identified US adults aged 18 to 64 years without opioid use in the year prior to surgery (ie, no opioid prescription fulfillments from 12 months to 1 month prior to the procedure). For patients filling a perioperative opioid prescription, we calculated the incidence of persistent opioid use for more than 90 days among opioid-naive patients after both minor surgical procedures (ie, varicose vein removal, laparoscopic cholecystectomy, laparoscopic appendectomy, hemorrhoidectomy, thyroidectomy, transurethral prostate surgery, parathyroidectomy, and carpal tunnel) and major surgical procedures (ie, ventral incisional hernia repair, colectomy, reflux surgery, bariatric surgery, and hysterectomy). We then assessed data for patient-level predictors of persistent opioid use. Main Outcomes and Measures The primary outcome was defined a priori prior to data extraction. The primary outcome was new persistent opioid use, which was defined as an opioid prescription fulfillment between 90 and 180 days after the surgical procedure. Results A total of 36 177 patients met the inclusion criteria, with 29 068 (80.3%) receiving minor surgical procedures and 7109 (19.7%) receiving major procedures. The cohort had a mean (SD) age of 44.6 (11.9) years and was predominately female (23 913 [66.1%]) and white (26 091 [72.1%]). The rates of new persistent opioid use were similar between the 2 groups, ranging from 5.9% to 6.5%. By comparison, the incidence in the nonoperative control cohort was only 0.4%. Risk factors independently associated with new persistent opioid use included preoperative tobacco use (adjusted odds ratio [aOR], 1.35; 95% CI, 1.21-1.49), alcohol and substance abuse disorders (aOR, 1.34; 95% CI, 1.05-1.72), mood disorders (aOR, 1.15; 95% CI, 1.01-1.30), anxiety (aOR, 1.25; 95% CI, 1.10-1.42), and preoperative pain disorders (back pain: aOR, 1.57; 95% CI, 1.42-1.75; neck pain: aOR, 1.22; 95% CI, 1.07-1.39; arthritis: aOR, 1.56; 95% CI, 1.40-1.73; and centralized pain: aOR, 1.39; 95% CI, 1.26-1.54). Conclusions and Relevance New persistent opioid use after surgery is common and is not significantly different between minor and major surgical procedures but rather associated with behavioral and pain disorders. This suggests its use is not due to surgical pain but addressable patient-level predictors. New persistent opioid use represents a common but previously underappreciated surgical complication that warrants increased awareness.

1,450 citations

Journal ArticleDOI
Robert S. Fisher1, Vicenta Salanova2, Thomas C. Witt2, Robert M. Worth2, Thomas R. Henry3, Robert E. Gross3, Kalarickal J. Oommen4, Ivan Osorio5, Jules M. Nazzaro5, Douglas Labar6, Michael G. Kaplitt6, Michael R. Sperling7, Evan Sandok8, John H. Neal8, Adrian Handforth9, John M. Stern10, Antonio DeSalles9, Steve Chung11, Andrew G. Shetter11, Donna Bergen12, Roy A.E. Bakay12, Jaimie M. Henderson1, Jacqueline A. French13, Gordon H. Baltuch13, William E. Rosenfeld, Andrew Youkilis, William J. Marks14, Paul A. Garcia14, Nicolas Barbaro14, Nathan B. Fountain15, Carl W. Bazil16, Robert R. Goodman16, Guy M. McKhann16, K. Babu Krishnamurthy17, Steven Papavassiliou17, Charles M. Epstein3, John R. Pollard13, Lisa Tonder18, Joan Grebin18, Robert J. Coffey18, Nina M. Graves18, Marc A. Dichter, William Elias, Paul Francel, Robert C. Frysinger, Kevin Graber, John Grant, Gary Heit, Susan T. Herman, Padmaja Kandula, Andres M. Kanner, Jeanne Ann King, Eric Kobylarz, Karen Lapp, Suzette M. LaRoche, Susan Lippmann, Rama Maganti, Timothy Mapstone, Dragos Sabau, Lara M. Schrader, Ashwini Sharan, Mike Smith, David M. Treiman, Steve Wilkinson, Steven Wong, Andro Zangaladze, Shelley Adderley, Brian Bridges, Mimi Callanan, Dawn Cordero, Cecelia Fields, Megan Johnson, MaryAnn Kavalir, Patsy Kretschmar, Carol Macpherson, Kathy Mancl, Marsha Manley, Stephanie Marsh, Jean Montgomery, Pam Mundt, Phani Priya Nekkalapu, Bill Nikolov, Bruce Palmer, Linda Perdue, Alison Randall, David Smith, Linda Smith, Kristen Strybing, Leigh Stott, Robin Taylor, Stacy Thompson, Zornitza Timenova, Bree Vogelsong, Virginia Balbona, Donna K. Broshek, Deborah A. Cahn-Weiner, Lisa Clift, Mary Davidson, Evan Drake, Sally Frutiger, Lynette Featherstone, Chris Grote, Dan Han, Dianne Henry, Jessica Horsfall, Andrea Hovick, Jennifer Gray, David Kareken, Kristin Kirlin, Debbie Livingood, Michele Meyer, Nancy Minniti, Jeannine Morrone Strupinsky, William Schultz, James Scott, Joseph I. Tracy, Stuart Waltonen, Penelope Ziefert, Carla Van Amburg, Mark E Burdelle, Sandra Clements, Robert Cox, Raeleen Dolin, Michelle Fulk, Harinder R. Kaur, Lawrence J. Hirsch, Thomas J. Hoeppner, Andrea Hurt, Mary Komosa, Scott E. Krahl, Laura Ponticello, Mark Quigg, Helene Quinn, Marvin A. Rossi, Patty Schaefer, Christopher Skidmore, Diane Sundstrom, Patricia Trudeau, Monica Volz, Norman C. Wang, Lynette Will, Carol Young 
TL;DR: A multicenter, double‐blind, randomized trial of bilateral stimulation of the anterior nuclei of the thalamus for localization‐related epilepsy is reported.
Abstract: Summary Purpose: We report a multicenter, double-blind, randomized trial of bilateral stimulation of the anterior nuclei of the thalamus for localization-related epilepsy Methods: Participants were adults with medically refractory partial seizures, including secondarily generalized seizures Half received stimulation and half no stimulation during a 3-month blinded phase; then all received unblinded stimulation Results: One hundred ten participants were randomized Baseline monthly median seizure frequency was 195 In the last month of the blinded phase the stimulated group had a 29% greater reduction in seizures compared with the control group, as estimated by a generalized estimating equations (GEE) model (p = 0002) Unadjusted median declines at the end of the blinded phase were 145% in the control group and 404% in the stimulated group Complex partial and “most severe” seizures were significantly reduced by stimulation By 2 years, there was a 56% median percent reduction in seizure frequency; 54% of patients had a seizure reduction of at least 50%, and 14 patients were seizure-free for at least 6 months Five deaths occurred and none were from implantation or stimulation No participant had symptomatic hemorrhage or brain infection Two participants had acute, transient stimulation-associated seizures Cognition and mood showed no group differences, but participants in the stimulated group were more likely to report depression or memory problems as adverse events Discussion: Bilateral stimulation of the anterior nuclei of the thalamus reduces seizures Benefit persisted for 2 years of study Complication rates were modest Deep brain stimulation of the anterior thalamus is useful for some people with medically refractory partial and secondarily generalized seizures

1,444 citations

Journal ArticleDOI
TL;DR: Patients with NASH are less likely to undergo liver transplantation (LT) andLess likely to survive for 90 days on the waitlist than patients with HCV, ALD, or HCV and ALD.

1,444 citations


Authors

Showing all 63886 results

NameH-indexPapersCitations
Michael Karin236704226485
Paul M. Ridker2331242245097
Eugene Braunwald2301711264576
Ralph B. D'Agostino2261287229636
John Q. Trojanowski2261467213948
Fred H. Gage216967185732
Edward Giovannucci2061671179875
Rob Knight2011061253207
Frank E. Speizer193636135891
Stephen V. Faraone1881427140298
Scott M. Grundy187841231821
Paul G. Richardson1831533155912
Peter W.F. Wilson181680139852
Dennis S. Charney179802122408
Kenneth C. Anderson1781138126072
Network Information
Related Institutions (5)
Medical University of South Carolina
45.4K papers, 1.7M citations

85% related

University of Texas Health Science Center at Houston
42.5K papers, 2.1M citations

85% related

University of Maryland, Baltimore
64.7K papers, 2.9M citations

84% related

University of California, San Francisco
186.2K papers, 12M citations

84% related

Anschutz Medical Campus
28.1K papers, 1.4M citations

84% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202314
2022137
20216,161
20205,712
20195,171
20184,497